ARTICLE | Clinical News
Ceftaroline: Phase III data
June 23, 2008 7:00 AM UTC
In the double-blind international Phase III CANVAS I and CANVAS II trials in 1,396 patients, ceftaroline met the primary endpoint of a clinical cure rate that was non-inferior to vancomycin plus aztre...